In cases of confirmed allergy to tirzepatide or excipients, discontinuation of Mounjaro and consideration of alternative glucose-lowering therapies would be necessary
Eligibility criteria apply to all trials
As GLP-1 therapies scale globally, peptide manufacturers must move towards GLP-1 peptide manufacturing capabilities that focus on: This approach supports faster development timelines, more predictable scale-ups, and more efficient use of manufacturing infrastructure
Because serum-containing media include abundant IGFBPs that would sequester native IGF-1, DES(1-3) IGF-1's reduced IGFBP affinity ensures that the applied dose approximates the actual receptor-activating dose
In the United States, patients will need to wait until at least 2031 before seeing generic versions of semaglutide medications
Meatballs and bites Microwave gently or reheat covered so they stay tender